Azacitidine as post-remission consolidation for sorafenib-induced remission of Fms-like tyrosine kinase-3 internal tandem duplication positive acute myeloid leukemia
Harinder Gill,
Cheuk-Him Man,
Alvin H.W. Ip,
William W.L. Choi,
Howard C.H. Chow,
Yok-Lam Kwong,
Anskar Y.H. Leung
Affiliations
Harinder Gill
Division of Haematology, Medical Oncology and Bone Marrow Transplantation, Department of Medicine, the University of Hong Kong, China
Cheuk-Him Man
Division of Haematology, Medical Oncology and Bone Marrow Transplantation, Department of Medicine, the University of Hong Kong, China
Alvin H.W. Ip
Department of Pathology, the University of Hong Kong, China
William W.L. Choi
Department of Pathology, the University of Hong Kong, China
Howard C.H. Chow
Division of Haematology, Medical Oncology and Bone Marrow Transplantation, Department of Medicine, the University of Hong Kong, China
Yok-Lam Kwong
Division of Haematology, Medical Oncology and Bone Marrow Transplantation, Department of Medicine, the University of Hong Kong, China
Anskar Y.H. Leung
Division of Haematology, Medical Oncology and Bone Marrow Transplantation, Department of Medicine, the University of Hong Kong, China
